Manufacturing & Packaging

How CDMOs will lead the way toward true cloud lab enablement

Site construction is part of a 10-year agreement with the Australian government

It has become critical to provide real-time accurate labeling information to labeling teams and healthcare providers as soon as a product change is approved by regulators. IQVIA‘s Cham Williams discusses the technology needed to support this shift and how these new solutions will minimize risks associated with regulatory compliance and increase patient safety.

Accreditation further extends CDMO's viral vector manufacturing capacity

Acquisition expected to be finalized in April

Survey conducted by HDA reveals thought process of manufacturers, distributors, and 3PLs

Moderna, Pfizer, and BioNTech seeking FDA approval for fourth dose of their respective shots

New center comes in response to increasing demand for firm’s medicines

CDMO’s Chenôve facility receives investment from French government

Deal expected to help expand its API production services

Agreement establishes company’s first mRNA manufacturing facility in Africa

The deal features a long-term supply and production agreement between the parties

Expansion features 11 new cGMP labs at Durham, NC location

A chat with Cardinal Health’s Joel Wayment, who dives into what can be done to help ensure that patients receive their necessary medications, no matter the conditions

The parties are partnering up to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies

Turnkey centers will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa

CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector

Will establish presence in Belgium, Denmark, Norway, the Netherlands, Poland and Sweden

Plans are underway to build Scottish fill-finish center, renovate API facility in England

The solution is a combination of cold chain logistics, serialization compliance and distribution

With the deal, the China-based CDMO grows its US presence

Anticipated yearly production is 2 million units

Newly acquired Performance Cell Manufacturing will now be known as Cellipont Bioservices

CDMO's new South Korean facility to offer a range of production services

Acquisition of AcKnowledge RS also expands company's IVD expertise

Will welcome seven temperature-controlled processing suites to accommodate various biologic drug needs

Partnership enhances CBM’s manufacturing capabilities in C&GT space

Agreement allows CRO to grow its manufacturing services, including in the chemistry space

Marks the first step in two-phase facility expansion project

Center’s 89,000 square-foot expansion expected to double its capacity